Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Shenzhen
Clinical trial register · China

Clinical Trials in Shenzhen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Shanghai 24 Beijing 19 Guangzhou 13 Hangzhou 12 Harbin 8
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Shenzhen Geno-Immune Medical Institute44 Beijing Biotech32 Sun Yat-sen University24 Bristol-Myers Squibb19 Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences13 Novartis Pharmaceuticals11 Peking University First Hospital11 Shenzhen University General Hospital10 Peking University Shenzhen Hospital10 Merck Sharp & Dohme LLC9 China National Center for Cardiovascular Diseases9 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.8 Hudson Biotech8 Biogen8 The University of Hong Kong-Shenzhen Hospital7 Pfizer6 Shenzhen People's Hospital6 AbbVie6 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.6 Cancer Institute and Hospital, Chinese Academy of Medical Sciences6 Nanfang Hospital, Southern Medical University5 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University5 Eighth Affiliated Hospital, Sun Yat-sen University5 AstraZeneca5 Alexion Pharmaceuticals, Inc.4 Takeda4 Eli Lilly and Company4 Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center4 The Hong Kong Polytechnic University4 Sanofi4 Allist Pharmaceuticals, Inc.3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 Ausper Biopharma Co., Ltd.3 Shenzhen Hospital of Southern Medical University3 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.3 Peking University People's Hospital3 The University of Hong Kong3 Shenzhen Salubris Pharmaceuticals Co., Ltd.3 Shenzhen Third People's Hospital3 Chinese University of Hong Kong3 City University of Hong Kong3 Second Xiangya Hospital of Central South University3 Sichuan Baili Pharmaceutical Co., Ltd.3 Akeso3 Shanghai Zhongshan Hospital3 Shenzhen Hemogen3 Beijing Tiantan Hospital3 Guangdong Provincial People's Hospital3 Novo Nordisk A/S3 UCB Biopharma SRL3 Eye & ENT Hospital of Fudan University3 Peking Union Medical College Hospital3 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.3 BeOne Medicines3 Otsuka Pharmaceutical Development & Commercialization, Inc.2 Celgene2 Fudan University2 Chinese SLE Treatment And Research Group2 Grit Biotechnology2 DK Medical Technology (Suzhou) Co., Ltd.2 Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.2 Shenzhen Kangning Hospital2 RenJi Hospital2 Hutchmed2 Jiangsu HengRui Medicine Co., Ltd.2 BioSyngen Pte Ltd2 The Chinese University of Hong Kong, Shenzhen2 GlaxoSmithKline2 Shanghai Henlius Biotech2 First Affiliated Hospital of Zhejiang University2 First Hospital of China Medical University2 Hangzhou Sumgen Biotech Co., Ltd.2 Zhongshan Ophthalmic Center, Sun Yat-sen University2 SyMap Medical (Suzhou), Ltd.2 Dermavon Holdings Limited2 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2 Bayer2 Shanghai Chest Hospital2 Mirati Therapeutics Inc.2 Bioray Laboratories2 Amgen2 Guangdong Association of Clinical Trials2 Junjie Hang2 Hoffmann-La Roche2 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.2 Shanghai Escugen Biotechnology Co., Ltd1 Zhiquan Hu1 Harbin Medical University1 CHENGNING Song1 Bausch & Lomb Incorporated1 Ying Zhu1 Xu Zhi-yuan1 The Children's Hospital of Zhejiang University School of Medicine1 Shandong Provincial Hospital1 Pan Xiangbin1 Xuanzhu Biopharmaceutical Co., Ltd.1 Xu Yong, MD1 Peking University Third Hospital1 Third Affiliated Hospital, Sun Yat-Sen University1 Shanghai Argo Biopharmaceutical Co., Ltd.1 GeneCradle Inc1 Xian-Janssen Pharmaceutical Ltd.1 Nanjing Leads Biolabs Co.,Ltd1 Shanghai Xinzhi BioMed Co., Ltd.1 Shenzhen Baoan District Fuyong People's Hospital1 Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd1 Changhai Hospital1 Angitia Biopharmaceuticals Guangzhou Limited1 Lepu Medical Technology (Beijing) Co., Ltd.1 Cai Qingxian1 Liaoning Chengda Biotechnology CO., LTD1 Beeline Medicines Corporation1 Turning Point Therapeutics, Inc.1 The Affiliated Hospital Of Guizhou Medical University1 Summit Therapeutics1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1 Cytokinetics1 Chongqing Precision Biotech Co., Ltd1 Regeneron Pharmaceuticals1 Xintian Pharmaceutical1 Xiang Gao1 Medtronic Cardiac Ablation Solutions1 Edwards Lifesciences1 LEO Pharma1 Song Peng1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Staidson (Beijing) Biopharmaceuticals Co., Ltd1 Inventiva Pharma1 SPH Sine Pharmaceutical Laboratories Co., Ltd.1 Eisai Inc.1 Huazhong University of Science and Technology1 Shenzhen Majory Biotechnology Co., Ltd.1 Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 Beijing Anzhen Hospital1 Yi Shuhua1 Rongrong Liu1 National Natural Science Foundation of China1 BGI, China1 Shanghai Huilun Pharmaceutical Co., Ltd.1 Shanghai Pulmonary Hospital, Shanghai, China1 Shanghai 6th People's Hospital1 Chongqing Jinsaixing Medical Technology Co., Ltd1 Shanghai University of Traditional Chinese Medicine1 Bio-Thera Solutions1 Shenzhen Beike Bio-Technology Co., Ltd.1 iCell Gene Therapeutics1 Zhejiang University1 Cell Energy Life Sciences Group Co. LTD1 Geneplus-Beijing Co. Ltd.1 Shanghai Junshi Bioscience Co., Ltd.1 ADARx Pharmaceuticals, Inc.1 Tang-Du Hospital1 Luo Xinxin1 Kunming Pharmaceuticals, Inc.1 Nanjing RegeneCore Biotech Co., Ltd.1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Hangzhou Valgen Medtech Co., Ltd1 Singlera Genomics Inc.1 Shanghai Changzheng Hospital1 Sixth Affiliated Hospital, Sun Yat-sen University1 Epygenix1 Synermore Biologics (Suzhou) Co., Ltd.1 Guangzhou 8th People's Hospital1 Ganzhou Hemay Pharmaceutical Co., Ltd1 Changchun GeneScience Pharmaceutical Co., Ltd.1 Shanghai Pharmaceuticals Holding Co., Ltd1 Obstetrics & Gynecology Hospital of Fudan University1 Genmab1 Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 Belief BioMed (Beijing) Co., Ltd1 Jiangsu Jingze Biopharmaceutical Co., Ltd.1 Suzhou Abogen Biosciences Co., Ltd.1 ShanShan Li1 Climb Bio, Inc.1 Chongqing Claruvis Pharmaceutical Co., Ltd.1 Beletalent (Zhuhai) Pharmaceutical Co., Ltd1 Herui Yao1 Chinese Academy of Medical Sciences1 Beijing Continent Pharmaceutical Co, Ltd.1 CARsgen Therapeutics Co., Ltd.1 Lining Xu1 Shenzhen Children's Hospital1 Shenzhen Maternity & Child Healthcare Hospital1 Chinese PLA General Hospital1 Biostime (Changsha) Nutrition Foods Limited1 Xuanwu Hospital, Beijing1 Ruijin Hospital1 The First Affiliated Hospital with Nanjing Medical University1 Liu yong1 Wenxian Li1 Bicetre Hospital1 Guangzhou Virotech Pharmaceutical Co., Ltd.1 Ion Beam Applications1 Pingshan District Maternal & Child Healthcare Hospital of Shenzhen1 Sinovac Life Sciences Co., Ltd.1 FangYi1 Cascade Pharmaceuticals, Inc1 Institute of Hematology & Blood Diseases Hospital, China1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 South China Normal University1 Ahon Pharmaceutical Co., Ltd.1 Vantive Health LLC1 ChunBao Li1 Xinghua Liu1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Hong Kong Metropolitan University1 Zenas BioPharma (USA), LLC1 Shenzhen NewDEL Biotech, Co., Ltd1 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 Servier1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 BioNTech SE1 Fengming Kong1 BioDlink Biopharm Co., Ltd.1 Shanghai Juncell Therapeutics1 a2 Milk Company Ltd.1 argenx1 PharmaEssentia1 TransThera Sciences (Nanjing), Inc.1 Johnson & Johnson Medical (Shanghai) Ltd.1 Capital Medical University1 Shanghai JunTop Biosciences Co., LTD1 Yuhan Corporation1 Qilu Hospital of Shandong University1 Longhua Hospital1 Beijing 302 Hospital1 Wan He1 NS Pharma, Inc.1 changjianhua1 Dong-Xin Wang1 Brii Biosciences Limited1 John R. Speakman1 Shanghai Jiao Tong University School of Medicine1 GeneSail Biotech (Shanghai) Co., Ltd.1 Shenzhen Bay Laboratory1 Clear sponsor filter
Target enrolment
to

Trials with a site in Shenzhen

3 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Akeso
Phase 3
198
Wuhu, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Zhuhai
2025-01-23
Not yet open
Akeso
Phase 2
24
Dongguan, Guangzhou, Shenzhen, Changsha, Ningbo
2024-12-30
Active, closed
Akeso
Phase 3
296
Hefei, Fuzhou, Xiamen, Dongguan, Guangzhou, Jiangmen, Shantou, Shenzhen
2021-08-16
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/shenzhen

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies with a site in Shenzhen that also match the filters currently applied.

How many clinical trials are recruiting in Shenzhen?

0 of the 3 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shenzhen), 3 studies
PhaseStudiesRecruitingShare
Phase 32066.7%
Phase 21033.3%

Most active sponsors

Lead sponsors with the most studies (Shenzhen)
Lead sponsorStudiesRecruiting
Akeso30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.